India's Rubicon Research hits record high as quarterly profit nearly doubles
** Shares of Rubicon Research RUBI.NS jump as much as 13% to a record high of 789 rupees, last up 4% ** Stock up for a third straight session ** Pharmaceutical formulations co's Q3 consol net profit nearly doubles to 728 mln rupees ($8.04 mln); rev from ops rises 51.7% y/y ** Stock up about ~21 from market debut in October 16, 2025 ($1 = 90.5200 Indian rupees) (Reporting by Brijesh Patel in Bengaluru) ((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))
Recent news on Rubicon Research
See all newsBrief: Rubicon Research Says USFDA Issues Form 483 With 1 Observation To Co's Satara Facility
Brief: General Atlantic Sells 13 Million Shares Of Rubicon Research Via Bulk Deal
India's Rubicon Research rises on quarterly profit, revenue jump
Brief: Rubicon Research June-Quarter Consol Net Profit 847.8 Million Rupees
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig